An effect of MAL2 silencing on cell proliferation, similar to that in lung cancer cell lines, was observed in breast [96], ovarian [131], pancreatic [148] and prostate [155] cancer cell lines, in which migration and invasion and the epithelial-to-mesenchymal transition were decreased. Here, MAL2 is linked to cancer.